Right now on fast, Merck versus the U.S. government, the drug giant suing Uncle Sam

saying DC's plan to negotiate drug pricing through Medicare is unconstitutional.

The details of the suit, the ripple effects from big farm are straight ahead.

Plus, the banking bounced the regionals rebounding today and surging over the last week.

What is behind this turnaround?

And could now be the time to bet again on the banks?

And later, a buzzkill for Boeing, their dreamliner Nightmare continues, homebuilders keep

hammering home gains and pouring a tall, cold glass of profits in the wake of the

bud light boycott.

I'm Melissa Lee.

This is Fast Money.

We're live at the Nasdaq Market site on the desk tonight.

Tim Seymour, Bono and Ison, Guy Dami and Mike Co.

We start off with a Merck meltdown, shares dropping nearly 3% today after the company

sued the Biden administration.

Over the inflation reduction act, the legislation would give Medicare the ability to negotiate

prescription drug prices down by as much as 60%.

We're calling the bargaining process a sham and, quote, tantamount to extortion among the

drugs that could be impacted, diabetes drug, genuvia, which brought Merck nearly $3 billion

in revenue last year.

And cancer treatment, key truda, with $21 billion in annual sales.

So, will other farmer companies follow Merck's lead?

...